DUBLIN, Ireland--(BUSINESS WIRE)--April 19, 2006--The Cubist Pharmaceuticals, Inc. (NASDAQ:CBST - News) Corporate Conference Call took place on 19-Apr-06 5:00pm ET. Mgt. reported 1Q06 GAAP net loss per share of $0.11. Revenue and bottom-line performance are on track with guidance. 2006 revenue guidance is $190-205m, and mgt. expects to be cash flow positive in 2006.
